CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- UPLOAD Other SEC-generated Letter
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 425 Deal Prospectus/Communication re Business Combination
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K/A Event Exhibits
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 8-K Event Restatement
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
Page 17 of 19 · 363 filings